| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Achieving Benchmarks for National Quality Indicators Reduces Recurrence and Progression in Non–muscle-invasive Bladder Cancer
|
Mariappan, Paramananthan
|
|
|
7 |
6 |
p. 1327-1337
|
article
|
| 2 |
Adjuvant Atezolizumab in Patients with Sarcomatoid Renal Cell Carcinoma: A Prespecified Subgroup Analysis of IMmotion010
|
Karam, Jose Antonio
|
|
|
7 |
6 |
p. 1175-1178
|
article
|
| 3 |
A Prospective Randomised Trial to Determine the Effect of a Reduced Versus Standard Dose of Enzalutamide on Side Effects in Frail Patients with Prostate Cancer
|
Boerrigter, Emmy
|
|
|
7 |
6 |
p. 1376-1383
|
article
|
| 4 |
Association Between GLP1R Agonists and Prostate, Kidney, and Bladder Cancers
|
Bukavina, Laura
|
|
|
7 |
6 |
p. 1543-1544
|
article
|
| 5 |
A Systematic Review and Meta-analysis of the Impact of Local Therapies on Local Event Suppression in Metastatic Hormone-sensitive Prostate Cancer
|
Tsuboi, Ichiro
|
|
|
7 |
6 |
p. 1185-1194
|
article
|
| 6 |
Benefit of Neoadjuvant Cisplatin-based Chemotherapy for Invasive Bladder Cancer Patients Treated with Radiation-based Therapy in a Real-world Setting: An Inverse Probability Treatment Weighted Analysis
|
Kool, Ronald
|
|
|
7 |
6 |
p. 1350-1357
|
article
|
| 7 |
Can Sarcomatoid Features Guide the Use of Adjuvant Atezolizumab Following Nephrectomy? Probably Not
|
Roussel, Eduard
|
|
|
7 |
6 |
p. 1162-1163
|
article
|
| 8 |
Circulating Biomarkers Predictive of Treatment Response in Patients with Hormone-sensitive or Castration-resistant Metastatic Prostate Cancer: A Systematic Review
|
Baboudjian, Michael
|
|
|
7 |
6 |
p. 1228-1245
|
article
|
| 9 |
Clinical Validation of the Intermediate-risk Non–muscle-invasive Bladder Cancer Scoring System and Substratification Model Proposed by the International Bladder Cancer Group: A Multicenter Young Academic Urologists Urothelial Working Group Collaboration
|
Soria, Francesco
|
|
|
7 |
6 |
p. 1497-1503
|
article
|
| 10 |
Clofarabine Has a Superior Therapeutic Window as compared to Gemcitabine in Preclinical Bladder Cancer Models
|
Gutmann, Michael
|
|
|
7 |
6 |
p. 1166-1170
|
article
|
| 11 |
Contemporary Diagnosis of Very Low-risk Prostate Cancer in a Multihospital Health Care System
|
Bennett 4th, Richard
|
|
|
7 |
6 |
p. 1179-1182
|
article
|
| 12 |
Contents
|
|
|
|
7 |
6 |
p. iii-x
|
article
|
| 13 |
Current Treatment Paradigms and Clinical Outcomes in Oligometastatic Prostate Cancer Patients: A Targeted Literature Review
|
Antonarakis, Emmanuel S.
|
|
|
7 |
6 |
p. 1280-1292
|
article
|
| 14 |
Development and Validation of a Multivariable Nomogram Predictive of Post-Nephroureterectomy Renal Function
|
Hensley, Patrick J.
|
|
|
7 |
6 |
p. 1313-1319
|
article
|
| 15 |
Differences in Tumor Gene Expression Profiles Between De Novo Metastatic Castration-sensitive Prostate Cancer and Metastatic Relapse After Prior Localized Therapy
|
Mathew Thomas, Vinay
|
|
|
7 |
6 |
p. 1462-1468
|
article
|
| 16 |
Editorial Board
|
|
|
|
7 |
6 |
p. i-ii
|
article
|
| 17 |
Effect of Radical Prostatectomy on Survival for Men with High-risk Nonmetastatic Prostate Cancer Features Selected According to STAMPEDE Criteria: An EMPaCT Study
|
Milonas, Daimantas
|
|
|
7 |
6 |
p. 1478-1486
|
article
|
| 18 |
Endoscopic Cryoablation Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma
|
Chen, Yiling
|
|
|
7 |
6 |
p. 1453-1461
|
article
|
| 19 |
Engaging in Clinical Research and Practice Approaches that Reduce Environmental Impact
|
Loeb, Stacy
|
|
|
7 |
6 |
p. 1451-1452
|
article
|
| 20 |
Functional Outcomes of Stereotactic Ablative Radiotherapy: There Is Room for Improvement
|
Bertolo, Riccardo
|
|
|
7 |
6 |
p. 1159-1161
|
article
|
| 21 |
Influential Factors Impacting Treatment Decision-making and Decision Regret in Patients with Localized or Locally Advanced Prostate Cancer: A Systematic Literature Review
|
Gartrell, Benjamin A.
|
|
|
7 |
6 |
p. 1216-1227
|
article
|
| 22 |
International Variations in Adherence to Quality Metrics for Locoregional Prostate Cancer
|
Weiner, Adam B.
|
|
|
7 |
6 |
p. 1469-1477
|
article
|
| 23 |
Large-scale Prospective Validation Study of a Multiplex RNA Urine Test for Noninvasive Detection of Upper Tract Urothelial Carcinoma
|
Zhang, Hao
|
|
|
7 |
6 |
p. 1384-1393
|
article
|
| 24 |
Long-term Renal Function Outcomes After Stereotactic Ablative Body Radiotherapy for Primary Renal Cell Carcinoma Including Patients with a Solitary Kidney: A Report from the International Radiosurgery Oncology Consortium of the Kidney
|
Tan, Vivian S.
|
|
|
7 |
6 |
p. 1527-1534
|
article
|
| 25 |
Magnetic Resonance Imaging–based Prostate Cancer Screening in Carriers of Pathogenic Germline Mutations: Interim Results from the Initial Screening Round of the Prostate Cancer Genetic Risk Evaluation and Screening Study
|
Amini, Andrew E.
|
|
|
7 |
6 |
p. 1358-1366
|
article
|
| 26 |
Maintaining Mental Health: Mindfulness Techniques for Clinicians
|
Parmar, Madhumita
|
|
|
7 |
6 |
p. 1183-1184
|
article
|
| 27 |
Mortality Risk for Patients with Biopsy Gleason Grade Group 1 Prostate Cancer
|
Tilki, Derya
|
|
|
7 |
6 |
p. 1520-1526
|
article
|
| 28 |
Mortality Risks Associated with Depression in Men with Prostate Cancer
|
Crump, Casey
|
|
|
7 |
6 |
p. 1411-1419
|
article
|
| 29 |
Multi-institutional Analysis of Metastasis-directed Therapy with or Without Androgen Deprivation Therapy in Oligometastatic Castration-sensitive Prostate Cancer
|
Deek, Matthew P.
|
|
|
7 |
6 |
p. 1403-1410
|
article
|
| 30 |
Novel Delivery Systems and Pharmacotherapeutic Approaches for the Treatment of Non–muscle-invasive Bladder Cancer
|
Guerrero-Ramos, Félix
|
|
|
7 |
6 |
p. 1267-1279
|
article
|
| 31 |
Patient Preference of Apalutamide Versus Enzalutamide for Recurrent or Metastatic Hormone-sensitive Prostate Cancer: An Open-label, Randomized, Crossover Trial
|
Ng, Chi-Fai
|
|
|
7 |
6 |
p. 1420-1430
|
article
|
| 32 |
Patient-reported Outcome Measures and Experience Measures After Active Surveillance Versus Radiation Therapy Versus Radical Prostatectomy for Prostate Cancer: A Systematic Review of Prospective Comparative Studies
|
Alberti, Andrea
|
|
|
7 |
6 |
p. 1255-1266
|
article
|
| 33 |
Phase 1/2 Randomized Clinical Trial of In-clinic acupuncture Prior to Bacillus Calmette-Guérin in Patients with High-risk Non–muscle-invasive Bladder Cancer
|
Psutka, Sarah P.
|
|
|
7 |
6 |
p. 1431-1440
|
article
|
| 34 |
Profiling Fibroblast Growth Factor Receptor 3 Expression Based on the Immune Microenvironment in Upper Tract Urothelial Carcinoma
|
Shigeta, Keisuke
|
|
|
7 |
6 |
p. 1338-1349
|
article
|
| 35 |
Prognostic and Predictive Role of SPOP Mutations in Prostate Cancer: A Systematic Review and Meta-analysis
|
Pedrani, Martino
|
|
|
7 |
6 |
p. 1199-1215
|
article
|
| 36 |
Progression-directed Therapy in Oligoprogressive Castration-resistant Prostate Cancer: Final Results from the Prospective, Single-arm, Phase 2 MEDCARE Trial
|
Rans, Kato
|
|
|
7 |
6 |
p. 1441-1450
|
article
|
| 37 |
Prostate Magnetic Resonance Imaging Using the Prostate Imaging for Recurrence Reporting (PI-RR) Scoring System to Detect Recurrent Prostate Cancer: A Systematic Review and Meta-analysis
|
Mourato, Felipe A.
|
|
|
7 |
6 |
p. 1246-1254
|
article
|
| 38 |
PTEN Loss Is Associated with Adverse Outcomes in the Setting of Salvage Radiation Therapy
|
Lee, Emerson
|
|
|
7 |
6 |
p. 1513-1519
|
article
|
| 39 |
Re: Guillaume Ploussard, Eric Barret, Gaëlle Fiard, et al. Transperineal Versus Transrectal Magnetic Resonance Imaging-targeted Biopsies for Prostate Cancer Diagnosis: Final Results of the Randomized PERFECT trial (CCAFU-PR1). Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2024.01.019
|
Lin, Fu-Xiang
|
|
|
7 |
6 |
p. 1549-1550
|
article
|
| 40 |
Re: Laura Elst, Manon T.A. Vreeburg, Hielke Martijn de Vries, et al. Corporal Skip Metastases in Penile Squamous Cell Carcinoma: An Unknown and Distinct Pattern of Spread with Poor Prognosis. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2023.09.005
|
Bandini, Marco
|
|
|
7 |
6 |
p. 1548
|
article
|
| 41 |
Reply to Alireza Ghoreifi and Hooman Djaladat’s Letter to the Editor re: Yiling Chen, Chenyang Xu, Zezhong Mou, et al. Endoscopic Cryoablation Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2024.04.012
|
Chen, Yiling
|
|
|
7 |
6 |
p. 1553-1554
|
article
|
| 42 |
Re: Yiling Chen, Chenyang Xu, Zezhong Mou, et al. Endoscopic Cryoablation Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2024.04.012
|
Ghoreifi, Alireza
|
|
|
7 |
6 |
p. 1551-1552
|
article
|
| 43 |
Robot-assisted Partial Nephrectomy for Hilar and Nonhilar Renal Masses: Comparison of Perioperative, Oncological, and Functional Results in a Multicentre Prospective Cohort (NEPRAH Study, UroCCR 175)
|
Sarkis, Julien
|
|
|
7 |
6 |
p. 1487-1496
|
article
|
| 44 |
Room for improvement when approaching RCC in the solitary kidney: surgery is not the only choice
|
Correa, Rohann J.M.
|
|
|
7 |
6 |
p. 1164-1165
|
article
|
| 45 |
Safety and Efficacy of Immediate Hyperthermic Intravesical Chemotherapy Following Transurethral Resection of Bladder Tumour (I-HIVEC)
|
Wong, Chris Ho-Ming
|
|
|
7 |
6 |
p. 1171-1174
|
article
|
| 46 |
The Added Value of Side-specific Systematic Biopsy in Patients Diagnosed by Magnetic Resonance Imaging–targeted Prostate Biopsy
|
Bourgeno, Henri-Alexandre
|
|
|
7 |
6 |
p. 1320-1326
|
article
|
| 47 |
The Role of Baseline Prostate-specific Antigen Value Prior to Age 60 in Predicting Lethal Prostate Cancer: Analysis of a Contemporary North American Cohort
|
Finati, Marco
|
|
|
7 |
6 |
p. 1535-1542
|
article
|
| 48 |
The Role of Mitomycin C in Intermediate-risk Non–muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis
|
Scilipoti, Pietro
|
|
|
7 |
6 |
p. 1293-1302
|
article
|
| 49 |
The State of Intermediate Clinical Endpoints as Surrogates for Overall Survival in Prostate Cancer in 2024
|
Miszczyk, Marcin
|
|
|
7 |
6 |
p. 1195-1198
|
article
|
| 50 |
Tolerability of Olaparib Combined with Abiraterone in Patients with Metastatic Castration-resistant Prostate Cancer: Further Results from the Phase 3 PROpel Trial
|
Saad, Fred
|
|
|
7 |
6 |
p. 1394-1402
|
article
|
| 51 |
Transperineal Versus Transrectal Magnetic Resonance Imaging–targeted Prostate Biopsy: A Systematic Review and Meta-analysis of Prospective Studies
|
Zattoni, Fabio
|
|
|
7 |
6 |
p. 1303-1312
|
article
|
| 52 |
UncoVer: A Web-based Resource for Single-cell and Spatially Resolved Omics Data in Uro-oncology
|
Lecuyer, Gwendoline C.V.
|
|
|
7 |
6 |
p. 1545-1547
|
article
|
| 53 |
Unlocking the Potential of Adequate Bacillus Calmette-Guérin Immunotherapy in Very-high-risk Non–muscle-invasive Bladder Carcinoma: A Multicenter Analysis of Oncological Outcomes and Risk Dynamics
|
Subiela, José Daniel
|
|
|
7 |
6 |
p. 1367-1375
|
article
|
| 54 |
Use of Decipher Prostate Biopsy Test in Patients with Favorable-risk Disease Undergoing Conservative Management or Radical Prostatectomy in the Surveillance, Epidemiology, and End Results Registry
|
Zhu, Alec
|
|
|
7 |
6 |
p. 1504-1512
|
article
|
Journal description